Suzhou Basecare Medical Corporation Limited (HKG:2170)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.400
-0.010 (-0.71%)
Jul 31, 2026, 3:55 PM HKT

HKG:2170 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-223.46-237.03-191.69-122.66-143.65
Depreciation & Amortization
48.3535.6619.538.395.59
Other Amortization
0.010.020.04--
Loss (Gain) From Sale of Assets
-0.440.660.18-8.7-0
Loss (Gain) From Sale of Investments
10.72-2.92.4-3.4-
Stock-Based Compensation
----7.91
Provision & Write-off of Bad Debts
4.8718.56---
Other Operating Activities
3.26-27.85-55.65-89.9611.27
Change in Accounts Receivable
-36.197.562.14-15.07-46.89
Change in Inventory
-9.893.94-21.15-14.74-24.1
Change in Accounts Payable
32.51-52.42-22.3930.187.75
Change in Unearned Revenue
1.6424.82-1.572-
Change in Other Net Operating Assets
0.74-0.140.9215.73-15.73
Operating Cash Flow
-167.88-229.12-267.23-188.77-197.85
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-85.57-93.3-104.21-128.45-28.9
Sale of Property, Plant & Equipment
0.581.540.880.080.36
Cash Acquisitions
---257.89-32.51-42.48
Divestitures
---3.2453.6-
Sale (Purchase) of Intangibles
----0.06-
Investment in Securities
83.77-111.88---
Other Investing Activities
9.3522.4439.6418.6514.42
Investing Cash Flow
8.12-181.19-324.81-88.7-56.6

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
47.2490.14196.7449.7543.65
Total Debt Issued
47.2490.14196.7449.7543.65
Long-Term Debt Repaid
-30.56-44.85-4.79-23.15-32.63
Total Debt Repaid
-30.56-44.85-4.79-23.15-32.63
Net Debt Issued (Repaid)
16.6745.3191.9526.611.01
Issuance of Common Stock
----1,678
Other Financing Activities
-12.85-11.52-1.4-3.09-93.69
Financing Cash Flow
3.8233.78190.5523.511,596

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.916.0612.5762.91-10.31
Net Cash Flow
-157.84-370.47-388.93-191.051,331

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-253.45-322.41-371.44-317.22-226.75
Free Cash Flow Growth
-----
Free Cash Flow Margin
-108.65%-107.79%-178.60%-225.14%-211.33%
Free Cash Flow Per Share
-0.93-1.18-1.36-1.16-0.85
Levered Free Cash Flow
-225.97-267.63-244.92-195.9-160.63
Unlevered Free Cash Flow
-217.77-261.77-243.28-195.59-159.84

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.110.470.240.190.24
Cash Income Tax Paid
0.44-0.023.26--
Change in Working Capital
-11.19-16.25-42.0518.1-78.96